Open AccessMP47-04 REFINING SELECTION CRITERIA FOR NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER: COMBINING CLINICAL RISK FEATURES AND INTRINSIC MOLECULAR SUBTYPES
Author(s) -
Jonathan J. Duplisea,
Michael Metcalfe,
Debasish Sundi,
Jed Ferguson,
Roger Li,
Shanna Pretzsch,
Ashish M. Kamat,
Neema Navai,
Jay B. Shah,
Jolanta Bondaruk,
Bogdan Czerniak,
Woonyoung Choi,
David J. McConkey,
Peter C. Black,
Colin P. Dinney
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.1483
Subject(s) - bladder cancer , cystectomy , medicine , chemotherapy , oncology , selection (genetic algorithm) , cancer , artificial intelligence , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom